Meet us at the 9th Drug Discovery Strategic Summit
We are attending the 9th Drug Discovery Strategic Summit in Boston, May 9-10, 2022. Connect with us and let us know if you’d like to schedule a meeting beforehand.
Meet us at Bio-IT World Conference & Expo 2022
Join us at Bio-IT World Conference & Expo, May 3-5, 2022, the world’s premier event showcasing the technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. Don’t hesitate to let us know if you’d like to schedule a meeting beforehand.
Colin Hill to Speak at The World Medical Innovation Forum 2022
This year, the World Medical Innovation Forum will explore the promise of new gene and cell therapies, the challenges to their development and investment and market dynamics. The forum features more than 200 CEOs, industry, investment, and government senior leaders from across the Gene and Cell Therapy (GCT) ecosystem. On Tuesday, May 3, Colin Hill, will […]
Meet us at AACR
The AACR Annual Meeting is the focal point of the cancer research community. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Meeting highlights the work of the best minds in cancer research from institutions all over the world. Joe F. Donahue, our Chief Business Officer […]
Colin Hill to Speak at The Longwood Healthcare Leaders Winter Webconference
On Thursday, January 6, Colin Hill, will be moderating a panel on Expediting Research for Treatments and Cures at the Longwood Healthcare Leaders winter webconference. He will be joined by Christopher Coburn, CIO, Mass General Brigham; Ray Deshaies, SVP, Research, Amgen; Raj Devraj, CEO, Rectify Pharma; Brian McVeigh, CEO, Code Biotherapeutics and Chen Schor, Chair, […]
BioCentury Article Highlights GNS Discoveries on Behalf of The MMRF
GNS Healthcare Inc. (Cambridge, Mass.) said it has identified four genes as “top drivers” of high-risk multiple myeloma. Using its machine learning technology, the company is collaborating with the Multiple Myeloma Research Foundation (MMRF) to analyze data in the foundation’s patient-driven, real-world CoMMpass study. Read the full story here.
GNS Healthcare Announces Investment by Horizon Healthcare Services, Inc. to Expand Strategic Partnership Focused on Precision Medicine in Population Health
CAMBRIDGE, Mass. – May 23, 2016 – GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, today announced an investment by Horizon Healthcare Services, Inc. (New Jersey). The investment supports a strategic collaboration between the companies and […]
Health Data Management Spotlights GNS Medication Adherence Program With OmedaRx
Medication management has evolved from intuition-based treatments to population health, which emerged in the mid-1990s with a top-down, rules-based approach that treats individuals as hypotheticals, says Colin Hill, chairman and CEO of GNS Healthcare. But traditional methods to determine which patients to reach out to don’t target people who are at high risk of negative […]
MobiHealthNews: GNS Healthcare raises $10M for precision medicine analytics
Cambridge, Massachusetts-based GNS Healthcare, which has developed an analytics tool for precision medicine and population health, raised $10 million from Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund. Existing investors Cambia Health Solutions, Heritage Provider Network, and Mitsui USA, the US subsidiary of Japan’s Mitsui & Co, also participated. This brings the company’s total funding […]
BioIT World: GNS Healthcare Announces $10M Financing, MMRF Study Results
GNS Healthcare announced a $10M Series C financing round today. New investors in this round—Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund LP—join previous investors including Cambia Health Solutions, California’s Heritage Provider Network, and Japan’s Mitsui & Co. U.S. subsidiary (“Mitsui USA”). GNS builds cloud-based big data solutions for precision medicine and […]